Trulieve Cannabis Corp (OTC: TCNNF) is a cannabis company that cultivates, processes, and retails cannabis products through its own dispensary network. Revenue is generated transactionally through direct-to-consumer sales of cannabis flower, concentrates, edibles, and related products at company-owned retail locations. The filing was submitted as a 10-K for the fiscal year ended, filed February 26, 2026 (accession 000175419526000019), but the excerpts provided do not disclose specific revenue figures, store counts, segment breakdowns, geographic mix, named competitors, or founding and leadership details in the portions made available. As a result, granular operating metrics cannot be reported here without risk of unsupported inference. Trulieve is incorporated under a Canadian jurisdiction and has securities registered under Section 12(g) of the Securities Exchange Act of 1934, with no securities listed on a national exchange as of the filing date.

Revenue model

Transactional retail sales of cannabis and cannabis-derived products through company-owned dispensaries. No subscription, licensing, or royalty revenue model is supported by the available filing excerpts.

Products and services

Cannabis products including flower, concentrates, edibles, and related items sold at retail dispensaries. Specific brand names and product-line revenue breakdowns are not supported by the available filing excerpts.

Customers and end markets

Direct-to-consumer retail cannabis customers. End market is state-regulated medical and adult-use cannabis. Customer concentration data is not disclosed in the available excerpts.

Value-chain role

Vertically integrated cannabis operator spanning cultivation, processing, and retail dispensary sales.

Geographic exposure

United States cannabis markets operating under state-level regulatory frameworks. Specific state-by-state footprint and store counts are not supported by the available filing excerpts.

Source: SEC 10-K, filed 2026-02-26

Industry: Medicinal Chemicals & Botanical Products Peers: Arvinas Inc Axsome Therapeutics Inc Pacira Biosciences Inc Filana Therapeutics Inc CORCEPT THERAPEUTICS INC Harmony Biosciences Holdings Inc Johnson & Johnson Prestige Consumer Healthcare Inc Ventyx Biosciences, Inc.